KorelKaplan

European Counsel

Munich + 49.89.20.60.42.212

Korel Kaplan advises financial sponsors, industrial corporate clients, and emerging technology companies on complex M&A transactions and strategic board and corporate matters. He has advised clients on cross-border deals and critical governance matters across the tech, automotive, energy, financial, and health care industries.

Korel regularly structures, drives, negotiates, and closes critical M&A transactions involving acquisitions or divestments of companies, competitive auctions, joint ventures, carve-outs, co-investments, and financing rounds. He has particular experience with leveraged buyouts, shareholder and investment agreements, buy-and-build strategies, large corporate carve-out deals, transactions triggering complex merger control or investment protection scrutiny, management participation programs, and transactional insurance products including warranty and indemnity (W&I) insurance.

Korel provides boardroom advice to management and supervisory boards on directors liability, corporate governance and best practices, general compliance matters, reorganizations, and negotiations or disputes requiring in-depth transactional or corporate law experience.

Prior to joining Jones Day, Korel practiced at an international firm where he advised financial sponsors such as Apax, BC Partners, Catella Group, Intek Group, Ontario Teachers' Pension Plan, SINO-CEEF, and Triton as well as corporate clients including Audi, BayWa, Continental, innogy, KME SE, lastminute.com group, Schneider Electric, and Ströer.

Experience

  • LyondellBasell invests in APK, a German plastics recycling companyJones Day represented LyondellBasell as the lead investor in the latest financing round of APK AG, a German plastics recycling company.
  • Timken acquires GGB Bearing Technology for $305 millionJones Day advised The Timken Company in the $305 million acquisition of GGB Bearing Technology (GGB), a division of Enpro, Industries (including exclusive negotiations with respect to the French operations of GGB).
  • LyondellBasell forms joint venture to build plastic waste sorting and recycling facilityJones Day advised LyondellBasell Industries Holdings B.V. in the formation of a joint venture with 23 Oaks Investments GmbH to create Source One Plastics, a joint venture that will build an energy efficient, advanced plastic waste sorting and recycling facility in Germany.
  • Bayer secures landmark victory in post-M&A ICC arbitration against BASFJones Day lawyers secured a landmark victory on behalf of Bayer AG in a multi-billion post-M&A arbitration against BASF SE.
  • ProSiebenSat.1 Media SE’s investment arm SevenVentures invests in GroverJones Day advised SevenVentures, the investment arm of ProSiebenSat.1 Media SE, in its investment in Grover, the leading consumer-tech subscription platform.
  • ProSiebenSat.1 sells moebel.de to XXXLutzJones Day advised ProSiebenSat.1 Media SE in the sale by subsidiary NuCom Group, in which General Atlantic also holds a stake, of moebel.de Einrichten & Wohnen AG to XXXLutz Group.
  • Hilti Group acquires Fieldwire for approximately $300 millionJones Day is advising the Hilti Group in its acquisition of Fieldwire, a San Francisco, California, based construction technology company specialized in construction project management software, for approximately $300 million.
  • ebase GmbH acquires securities business of Augsburger AktienbankJones Day advised European Bank of Financial Services GmbH (ebase) in the acquisition of the securities business of Augsburger Aktienbank AG.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
  • SevenVentures invests in GroverJones Day represented SevenVentures, the investment arm of ProSiebenSat.1 Group, in connection with its investment in Grover, Europe's market leader in consumer tech subscriptions.
  • EMERAM Capital Partners sells portfolio company MEONA to Trill ImpactJones Day represented EMERAM Capital Partners GmbH, one of the leading investment companies for medium-sized companies in the German-speaking region, in the sale of its portfolio company MEONA, an innovation leader for clinical software, to the private equity firm, Trill Impact.
  • Astellas returns rights to Eligard® in Europe, Middle East, CIS, and Asia to TolmarJones Day represented Astellas Pharma Europe Ltd. in connection with a series of transactions, including the sale of related assets, in which Astellas returned its in-licensing rights to Eligard® (leuprorelin acetate for injectable suspension), a treatment for advanced prostate cancer, sold by Astellas in Europe, the Middle East, the Commonwealth of Independent States (CIS) and Asia, to Tolmar International Limited.
  • Astellas transfers DIFICLIR in Europe, Middle East, Africa, and selected CIS to Swiss Tillotts Pharma AG for €109 millionJones Day advised Astellas Pharma Europe Ltd. on the sale of distribution rights to the product "DIFICLIR" in Europe, Middle East, Africa, and selected Commonwealth of Independent States (CIS) countries to Swiss Tillotts Pharma AG for €109 million.
  • Materion acquires Optics Balzers, AG for $160 millionJones Day advised Materion Corporation, a global supplier of highly engineered advanced enabling materials, in its $160 million acquisition of Optics Balzers, AG, an industry leader in thin film optical coatings.
  • yabeo Advisors participates in €60 million Series C financing round of solarisBank AGJones Day advised yabeo Advisors GmbH in its minority stake investment in solarisBank AG, Europe's leading Banking-as-a-Service platform.
  • Edge Case Research acquires TerraLoupe TechnologyJones Day advised Edge Case Research, Inc. in its acquisition of assets of TerraLoupe GmbH.